AXON — Axon Enterprise, Inc.

AXON Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics:

• Revenue: Q4 revenue grew 39% year-over-year to $797 million, marking the eighth consecutive quarter of over 30% growth.
• Bookings: Full-year bookings exceeded $7 billion, up more than 40% from the previous year. Q4 bookings rose over 50%.
• Net Revenue Retention (NRR): Expanded to 125%, indicating strong adoption of new products by existing customers.
• Annual Recurring Revenue (ARR): Grew 35% year-over-year to over $1.3 billion.
• Adjusted EBITDA: Increased 46% year-over-year to $206 million, with an adjusted EBITDA margin of 25.9%.
• Gross Margin: Adjusted gross margin was 61.1%, slightly down due to product mix and tariffs.
• Free Cash Flow: Operating cash flow was $217 million, with a target of 60% free cash flow conversion on adjusted EBITDA for 2026.

2. Strategic Updates and Business Highlights:

• Product Performance: New product bookings, including AI and Fusus, totaled over $1 billion for the year, nearly tripling 2024 figures.
• Market Expansion: Bookings from new and emerging markets surpassed $2 billion, with significant growth in international corrections and justice.
• AI Integration: The AI Era Plan accounted for approximately $750 million in bookings, reflecting the company’s focus on integrating AI into its offerings.
• Acquisitions: Closed the acquisition of Prepared in Q4 and Carbyne in January 2026, aimed at enhancing the 911 market capabilities.
• Innovation: Continued investment in R&D and new product development, with a focus on integrated hardware and software solutions.

3. Forward Guidance and Outlook:

• 2026 Revenue Growth: Projected revenue growth of 27% to 30% year-over-year, the strongest outlook heading into a new year.
• Adjusted EBITDA Margin: Expected to maintain an adjusted EBITDA margin of 25.5% for 2026.
• Long-term Targets: New 2028 targets set for approximately $6 billion in revenue and a 28% adjusted EBITDA margin, implying continued growth and margin expansion.

4. Bad News, Challenges, or Points of Concern:

• Tariffs and Inflation: Ongoing global tariffs and inflationary pressures on component costs may impact margins.
• Seasonality: Q1 is typically slower for new bookings and free cash flow conversion due to seasonal factors like bonuses and commissions.
• Regulatory Risks: Concerns about data privacy and compliance in the context of expanding AI capabilities and public scrutiny.
• Execution Risks: The need for continued execution and customer satisfaction to maintain momentum in bookings and revenue growth.

5. Notable Q&A Insights:

• Bookings Growth: Management refrained from providing specific bookings guidance but expressed confidence in demand across core markets and new products.
• AI Adoption: AI Era Plan adoption is often bundled with other products, indicating a synergistic approach to customer engagement.
• Enterprise Market Strategy: Emphasis on making early enterprise customers successful to drive future growth; the approach varies based on specific customer needs.
• International Expansion: Management noted that while there was significant growth in international bookings, sustaining that momentum will require continued focus and execution.
• Drone Legislation: Management highlighted ongoing discussions about regulatory changes that could expand capabilities for state and local agencies regarding drone mitigation.

This summary encapsulates the key financial metrics, strategic initiatives, forward-looking guidance, challenges, and insights from the Q&A session, providing a comprehensive overview of Axon's performance and outlook.